Literature DB >> 20016246

Evidence for the involvement of glutamatergic and neurokinin 1 receptors in the antinociception elicited by tramadol in mice.

Cristiano R Jesse1, Cristina W Nogueira.   

Abstract

This study was designed to evaluate the role of spinal glutamatergic receptors and neurokinin 1-mediated pathway in the antinociception elicited by tramadol in mice. Tramadol (1-50 mg/kg), given intraperitoneally (i.p.), produced significant inhibition of the biting behavior induced by intrathecal injection (i.t.) of glutamate (175 nmol/site), alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA; 135 pmol/site), (+/-)-1-aminocyclopentane-trans-1,3-dicarboxylic acid (trans-ACPD; 50 nmol/site) and substance P (SP, 135 ng/site). Tramadol injected by the i.t. route (25-400 nmol/site) also produced inhibition of glutamate-, AMPA-, trans-ACPD- and SP-induced biting response. Pretreatment with tramadol by the i.p. and i.t. routes had no significant effect against the kainate- and N-methyl-D-aspartic acid (NMDA)-mediated biting response in mice. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20016246     DOI: 10.1159/000265551

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  2 in total

Review 1.  Revisiting Tramadol: A Multi-Modal Agent for Pain Management.

Authors:  Ahmed Barakat
Journal:  CNS Drugs       Date:  2019-05       Impact factor: 5.749

2.  The spinal NR2BR/ERK2 pathway as a target for the central sensitization of collagen-induced arthritis pain.

Authors:  Yingming Xu; Kui Zhang; Jinlin Miao; Peng Zhao; Minghua Lv; Jia Li; Xianghui Fu; Xing Luo; Ping Zhu
Journal:  PLoS One       Date:  2018-07-19       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.